Role of the Immune System in Preventing Laryngeal Cancer

Recruiting now

Conditions studied: Head & Neck Cancer

In brief

Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation

Key facts

Study ID

NCT07508319

Run by

European Institute of Oncology

People needed

3

Starts

2025-11-19

Expected to finish

2026-12-31

Last updated by the study team

2026-04-02

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histopathological diagnosis of laryngeal dysplasia.
• Age >18 years and informed consent.

You may not qualify if…

• Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions.
• Congenital or acquired immunodeficiency disorders.
• Synchronous malignancies.
• Immunosuppressive therapy.
• Age <18 years or absence of research consent.

Where it is running

• European Institute of Oncology — Milan, MI, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.